News Headlines

Display #
Title
Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs
Novartis gets European OK for biosimilar of Amgen’s Enbrel
New form of Roche’s Esbriet approved in Europe for lung disorder
What makes stem cells into perfect allrounders
Dimension Therapeutics Pink Slips 25 Percent of Workforce
Merck’s cholesterol drug clears main goal in late-stage study
FDA Tackles Drug Competition
Alder’s migraine drug data disappoints
DePuy Synthes Announces Acquisition of Sentio to Enable Innovation in Minimally Invasive Spine Surgery
Cancer hijacks natural cell process to survive
Investors Relieved as Seattle Genetics Pulls Out Win for Phase III Lymphoma Trial
New Roche hemophilia drug prevents bleeds
FDA Approves First Anticoagulant for Hospitals
Medtronic deal with Aetna ties insulin pump payment to patient results
EU tests limits of drug pricing freedom in landmark probe
U.S. Senate Republicans to issue revised healthcare bill: Senate aide
Mobile Technology in Heart Failure Clinical Trials: Connecting with Patients Where They Live and Work
FDA Approves Rituxan Hycela for Subcutaneous Injection in Certain Blood Cancers
Does the emperor have clothes?
bluebird bio Touts Impressive Data From Late-Stage Gene Therapy Study
FDA Calls Cara Therapeutics’ Kidney Disease Drug a Breakthrough, Stock Soars
Novartis breast cancer drug Kisqali wins European panel backing
FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
Germany’s Merck gets EU backing for oral MS drug
EU backs second biosimilar copy of Humira
EU regulators greenlight U.S. biotech Aveo’s kidney cancer drug
Systems pharmacology modelers accelerate drug discovery in Alzheimer's
Merck Foundation established
Kamada Withdraws MAA For Inhaled Alpha-1 Antitrypsin
FDA Slaps Hold on IND for Vadastuximab Talirine